USPTO serial 97583755
ARKE HEALTH
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAPTER, ALAIN J
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ARKE HEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Aaron Y. Silverstein
Aaron Y. Silverstein SAUNDERS & SILVERSTEIN LLP14 CEDAR STREET, SUITE 224AMESBURY, MA 01913United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable or recorded computer programs using artificial intelligence for machine learning; downloadable computer software using artificial intelligence and machine learning for inputting, collecting, analyzing, storing, managing, recording, authenticating, transmitting, and receiving data for health treatment and diagnostic purposes; downloadable computer programs using artificial intelligence for machine learning in the fields of healthcare, medicine genetics, biology, life sciences, biotechnology, drug development, research and development, insurance, and pharmaceuticals | ACTIVE | — |
| 035 | Healthcare ecosystem, namely, procuring and fulfilling government contracts in the field of healthcare utilizing artificial intelligence and machine learning technologies; Healthcare ecosystem, namely, procuring, subcontracting, and maintaining business and contractual relationships in the field of healthcare | ACTIVE | — |
| 042 | Scientific and product research and development services; drug discovery services in the nature of pharmaceutical research and development services; biotechnology research, consulting and development; providing temporary use of online non-downloadable software using machine learning algorithms for inputting, collecting, analyzing, storing, managing, recording, authenticating, transmitting, and receiving data for health treatment and diagnostic purposes; providing temporary use of online non-downloadable software and non-downloadable software platforms in the fields of healthcare, medicine, genetics, biology, life sciences, biotechnology, drug development, research and development, insurance, and pharmaceuticals that also include the use of artificial intelligence and machine learning for inputting, collecting, analyzing, storing, managing, recording, authenticating, transmitting, and receiving data for health treatment and diagnostic purposes; scientific research, product development, and scientific research consulting in the fields of healthcare, medicine, genetics, biology, life sciences, biotechnology, drug development, and pharmaceuticals; consulting services in the field of healthcare, medicine, genetics, biology, life sciences, biotechnology, drug development, and pharmaceuticals; pharmaceutical research and drug development services; providing scientific and medical research information in the field of genetics, biology, life sciences, biotechnology, drug development, and pharmaceuticals; providing interactive websites featuring technology in the fields of healthcare, medicine, genetics, biology, life sciences, biotechnology, drug development, research and development, insurance, and pharmaceuticals that also includes the use of artificial intelligence, and machine learning for inputting, collecting, analyzing, storing, managing, recording, authenticating, transmitting, and receiving data for health treatment and diagnostic purposes; providing online databases featuring information relating to scientific and medical research in the fields of healthcare, medicine, genetics, biology, life sciences, biotechnology, drug development, research and development, insurance, and pharmaceuticals that also includes the use of artificial intelligence, and machine learning | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Red Cell Partners, LLC
- Other trademarks owned by Red Cell Partners, LLC
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named ARKE HEALTH
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 17, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 17, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 16, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 21, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 21, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 1, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 15, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 10, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 10, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 10, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 16, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Feb 16, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 16, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 16, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 26, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 26, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 26, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 17, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 16, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 16, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 13, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Oct 13, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Aug 22, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 22, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 22, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 13, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 29, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 29, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Mar 27, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jan 4, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 4, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 4, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 2, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 26, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 12, 2022 | NWAP | NEW APPLICATION ENTERED | — |